NUMERO: #20260534

Título: DIAGNOSTIC PERFORMANCE IN ASYNCHRONOUS TELEDENTISTRY FOR ORAL LESIONS: INSIGHTS FROM PRIMARY CARE

Nome do Apresentador: Ana Beatriz Aparecida Silva REZENDE

Categoria do Trabalho: Pôster - Investigação Original (IO)

Área Temática: Estomatologia

Resumo: Objective:
To evaluate diagnostic agreement and reclassification patterns between primary care professionals and specialist consultants in asynchronous teledentistry for oral lesion assessment.

Study Design:
Retrospective cross-sectional study including 600 teleconsultations submitted to a public teledentistry platform (2022-2025). Diagnostic hypotheses were categorized into benign lesions, potentially malignant disorders, and malignant neoplasms. Agreement was assessed using Cohen's kappa.

Results:
Among 479 cases, moderate agreement was observed (κ = 0.49), with overall concordance of 78.5%. Lesions initially classified as benign were upgraded in 12.3% of cases, while 41.7% of lesions suspected as malignant were reclassified into lower-risk categories. Potentially malignant disorders represented 23.0% and malignant neoplasms 18.7% of specialist diagnoses. Most cases were asymptomatic (67.3%), and patient-related factors showed no consistent association with diagnostic discrepancy.

Conclusion:
Asynchronous teledentistry demonstrated moderate diagnostic performance and clinically relevant reclassification patterns, supporting its role as a decision-support tool for oral lesion assessment and risk stratification in primary care.

Funding:FAPEMIG (Grant No. APQ-03579-23).

Autor 1:  Ana Beatriz Aparecida Silva REZENDE

E-mail 1:  [email protected]

Autor 2:   Davi Figueiredo VALADARES

E-mail 2:  [email protected]

Autor 3 :  Caroline Miranda PERNAMBUCANO

E-mail 3:  [email protected]

Autor 4:  Edson Hilan Gomes de LUCENA

E-mail 4:  [email protected]

Autor 5:  Paulo Rogerio Ferreti BONAM

E-mail 5:  [email protected]

Autor 6:  Leonardo Amaral dos REIS

E-mail 6:  [email protected]

Autor 7:  Lívia Maris Ribeiro Paranaíba DIAS

E-mail 7:  [email protected]